These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 11210745
1. [Allergen-peptide immunotherapy against Japanese cedar pollinosis]. Saito S. Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):568-70. PubMed ID: 11210745 [No Abstract] [Full Text] [Related]
2. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens. Hirahara K, Tatsuta T, Takatori T, Ohtsuki M, Kirinaka H, Kawaguchi J, Serizawa N, Taniguchi Y, Saito S, Sakaguchi M, Inouye S, Shiraishi A. J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388 [Abstract] [Full Text] [Related]
3. Approaches to immunotherapies for Japanese cedar pollinosis. Sakaguchi M, Hirahara K, Fujimura T, Toda M. Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607 [Abstract] [Full Text] [Related]
4. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine. Hiroi T, Takaiwa F. Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651 [Abstract] [Full Text] [Related]
5. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen. Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K. Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778 [Abstract] [Full Text] [Related]
6. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis. Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S. Allergol Int; 2009 Mar; 58(1):63-70. PubMed ID: 19050376 [Abstract] [Full Text] [Related]
7. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H. Int Arch Allergy Immunol; 2008 Mar; 146(1):76-84. PubMed ID: 18087165 [Abstract] [Full Text] [Related]
8. 26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from Japanese cedar pollen allergens. Domon E, Takagi H, Hirose S, Sugita K, Kasahara S, Ebinuma H, Takaiwa F. J Agric Food Chem; 2009 Jun 24; 57(12):5633-8. PubMed ID: 19462978 [Abstract] [Full Text] [Related]
9. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Arerugi; 2008 May 24; 57(5):558-61. PubMed ID: 18520178 [Abstract] [Full Text] [Related]
10. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis]. Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K. Arerugi; 2009 Feb 24; 58(2):124-32. PubMed ID: 19329875 [Abstract] [Full Text] [Related]
11. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study. Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y. Clin Exp Allergy; 2008 Mar 24; 38(3):405-12. PubMed ID: 18070160 [Abstract] [Full Text] [Related]
12. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract. Kawakami A, Koketsu R, Suzukawa M, Nagao M, Hiraguchi Y, Tokuda R, Fujisawa T, Nagase H, Ohta K, Yamamoto K, Yamaguchi M. Int Arch Allergy Immunol; 2008 Mar 24; 146 Suppl 1():54-60. PubMed ID: 18504408 [Abstract] [Full Text] [Related]
13. Identification of peptides containing T-cell epitopes of Japanese cedar (Cryptomeria japonica) pollen allergen (Cry j 1) in dogs. Masuda K, Sakaguchi M, Saito S, Yasueda H, Iwabuchi S, Tsukui T, Hayashi N, Nakao Y, Kurata K, Maeda S, Ohno K, Tsujimoto H. Vet Immunol Immunopathol; 2004 Nov 24; 102(1-2):45-52. PubMed ID: 15451614 [Abstract] [Full Text] [Related]
14. A rice-based edible vaccine expressing multiple T-cell epitopes to induce oral tolerance and inhibit allergy. Takaiwa F. Immunol Allergy Clin North Am; 2007 Feb 24; 27(1):129-39. PubMed ID: 17276883 [Abstract] [Full Text] [Related]
15. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level. Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K. Clin Exp Allergy; 2005 May 24; 35(5):664-71. PubMed ID: 15898991 [Abstract] [Full Text] [Related]
16. Sublingual immunotherapy for Japanese cedar pollinosis. Okubo K, Gotoh M. Allergol Int; 2009 Jun 24; 58(2):149-54. PubMed ID: 19390236 [Abstract] [Full Text] [Related]
17. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells. Masuda K. Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609 [Abstract] [Full Text] [Related]
18. Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology. Kitaoka M, Shin Y, Kamiya N, Kawabe Y, Kamihira M, Goto M. AAPS PharmSciTech; 2015 Dec 18; 16(6):1418-24. PubMed ID: 25986596 [Abstract] [Full Text] [Related]
19. Intraoral administration of a T-cell epitope peptide induces immunological tolerance in Cry j 2-sensitized mice. Yoshitomi T, Nakagami Y, Hirahara K, Taniguchi Y, Sakaguchi M, Yamashita M. J Pept Sci; 2007 Aug 18; 13(8):499-503. PubMed ID: 17600865 [Abstract] [Full Text] [Related]
20. Present situation of cedar pollinosis in Japan and its immune responses. Okamoto Y, Horiguchi S, Yamamoto H, Yonekura S, Hanazawa T. Allergol Int; 2009 Jun 18; 58(2):155-62. PubMed ID: 19307773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]